share_log

Change Healthcare Inc. (NASDAQ:CHNG) Shares Bought by Zurcher Kantonalbank Zurich Cantonalbank

Change Healthcare Inc. (NASDAQ:CHNG) Shares Bought by Zurcher Kantonalbank Zurich Cantonalbank

Change Healthcare Inc.(納斯達克代碼:CHNG)被蘇黎世廣東銀行購買的股票
Defense World ·  2022/07/13 16:51

Zurcher Kantonalbank Zurich Cantonalbank raised its holdings in Change Healthcare Inc. (NASDAQ:CHNG – Get Rating) by 12.2% in the first quarter, Holdings Channel.com reports. The fund owned 30,602 shares of the company's stock after acquiring an additional 3,337 shares during the period. Zurcher Kantonalbank Zurich Cantonalbank's holdings in Change Healthcare were worth $667,000 at the end of the most recent reporting period.

據Holdings Channel.com報道,今年第一季度,Zurcher Kantonalbank將其在Change Healthcare Inc.(納斯達克代碼:Chng-Get Rating)的持股比例提高了12.2%。該基金持有該公司30,602股股票,在此期間又購買了3,337股。在最近一個報告期結束時,Zurcher Kantonalbank蘇黎世廣東銀行在Change Healthcare持有的股份價值66.7萬美元。

Other hedge funds and other institutional investors have also modified their holdings of the company. Alliancebernstein L.P. lifted its stake in Change Healthcare by 9.8% during the fourth quarter. Alliancebernstein L.P. now owns 10,239,418 shares of the company's stock valued at $218,919,000 after buying an additional 914,897 shares in the last quarter. Boston Partners lifted its stake in Change Healthcare by 18.1% during the fourth quarter. Boston Partners now owns 6,082,602 shares of the company's stock valued at $129,857,000 after buying an additional 933,892 shares in the last quarter. National Bank of Canada FI purchased a new stake in Change Healthcare during the fourth quarter valued at about $83,899,000. State Street Corp lifted its stake in Change Healthcare by 4.8% during the fourth quarter. State Street Corp now owns 3,769,328 shares of the company's stock valued at $80,588,000 after buying an additional 171,841 shares in the last quarter. Finally, Versor Investments LP lifted its stake in Change Healthcare by 49.6% during the fourth quarter. Versor Investments LP now owns 3,735,775 shares of the company's stock valued at $79,871,000 after buying an additional 1,238,976 shares in the last quarter. 96.09% of the stock is owned by institutional investors.

其他對衝基金和其他機構投資者也調整了對該公司的持股。聯合伯恩斯坦公司在第四季度將其在Change Healthcare的持股比例提高了9.8%。聯合伯恩斯坦公司現在擁有10,239,418股該公司股票,價值218,919,000美元,在上個季度又購買了914,897股。波士頓合夥公司在第四季度將其在Change Healthcare的持股增加了18.1%。波士頓合夥公司現在持有該公司6082,602股股票,價值129,857,000美元,上個季度又購買了933,892股。加拿大國民銀行FI在第四季度購買了Change Healthcare的新股份,價值約83,899,000美元。道富集團在第四季度增持了Change Healthcare 4.8%的股份。道富銀行目前持有該公司3,769,328股股票,價值80,588,000美元,上一季度又購買了171,841股。最後,Versor Investments LP在第四季度將其在Change Healthcare的持股比例提高了49.6%。Versor Investments LP現在擁有3735,775股該公司股票,價值79,871,000美元,上個季度又購買了1,238,976股。96.09%的股份由機構投資者持有。

Get
到達
Change Healthcare
改變醫療保健
alerts:
警報:

A number of analysts have commented on the stock. William Blair reaffirmed a "market perform" rating on shares of Change Healthcare in a research note on Friday, June 3rd. Piper Sandler reissued a "buy" rating and issued a $26.00 price target on shares of Change Healthcare in a research report on Tuesday, April 26th. Credit Suisse Group increased their price target on shares of Change Healthcare from $25.75 to $27.75 and gave the stock a "neutral" rating in a research report on Tuesday, May 31st. Cowen set a $27.75 price target on shares of Change Healthcare in a research report on Monday, June 20th. Finally, SVB Leerink reissued an "outperform" rating on shares of Change Healthcare in a research report on Thursday, May 26th. Two research analysts have rated the stock with a hold rating and four have given a buy rating to the stock. According to MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and a consensus price target of $27.00.

一些分析師對該股發表了評論。威廉·布萊爾在6月3日星期五的一份研究報告中重申了對Change Healthcare股票的“市場表現”評級。派珀·桑德勒在4月26日(週二)的一份研究報告中重新發布了對Change Healthcare的評級,併為其股票設定了26.00美元的目標價。瑞士信貸集團在5月31日週二的一份研究報告中將Change Healthcare的股票目標價從25.75美元上調至27.75美元,並給予該股“中性”評級。考恩在6月20日星期一的一份研究報告中為Change Healthcare的股票設定了27.75美元的目標價。最後,SVB Leerink在5月26日(週四)的一份研究報告中重新發布了對Change Healthcare股票的“跑贏大盤”評級。兩名研究分析師對該股的評級為持有,四名分析師給予該股買入評級。根據MarketBeat.com的數據,該股的共識評級為“適度買入”,共識目標價為27.00美元。

NASDAQ:CHNG opened at $22.99 on Wednesday. The stock's 50 day moving average price is $23.30 and its 200 day moving average price is $22.11. Change Healthcare Inc. has a 52 week low of $18.97 and a 52 week high of $24.12. The company has a market capitalization of $7.32 billion, a P/E ratio of -127.72, a P/E/G ratio of 2.23 and a beta of 1.08. The company has a debt-to-equity ratio of 1.40, a quick ratio of 1.22 and a current ratio of 1.22.
納斯達克:長城週三開盤報22.99美元。該股的50日移動均線價格為23.30美元,200日移動均線價格為22.11美元。Change Healthcare Inc.的股價為18.97美元,為52周低點,52周高點為24.12美元。該公司市值為73.2億美元,市盈率為-127.72,市盈率為2.23%,貝塔係數為1.08.該公司的債務權益比率為1.40,速動比率為1.22,流動比率為1.22。

Change Healthcare (NASDAQ:CHNG – Get Rating) last released its quarterly earnings data on Wednesday, May 25th. The company reported $0.34 EPS for the quarter, missing analysts' consensus estimates of $0.37 by ($0.03). Change Healthcare had a positive return on equity of 12.91% and a negative net margin of 1.65%. The firm had revenue of $920.13 million during the quarter, compared to analyst estimates of $902.86 million. During the same quarter in the prior year, the company posted $0.36 EPS. The company's quarterly revenue was up 7.6% on a year-over-year basis. As a group, sell-side analysts forecast that Change Healthcare Inc. will post 1.3 earnings per share for the current fiscal year.

Change Healthcare(納斯達克:Chng-Get Rating)最近一次發佈季度收益數據是在5月25日星期三。該公司公佈本季度每股收益為0.34美元,低於分析師普遍預期的0.37美元(0.03美元)。Change Healthcare的股本回報率為正12.91%,淨利潤率為負1.65%。該公司本季度營收為9.2013億美元,而分析師預期為9.0286億美元。去年同期,該公司公佈的每股收益為0.36美元。該公司季度營收同比增長7.6%。賣方分析師預計,Change Healthcare Inc.本財年每股收益將達到1.3美元。

Change Healthcare Company Profile (Get Rating)

更改醫療保健公司簡介(獲取評級)

Change Healthcare Inc, an independent healthcare technology company, provides data and analytics-driven solutions to enhance clinical, financial, administrative, and patient engagement outcomes in the United States healthcare system. It operates through three segments: Software and Analytics, Network Solutions, and Technology-Enabled Services.

Change Healthcare Inc.是一家獨立的醫療技術公司,提供數據和分析驅動的解決方案,以增強美國醫療系統的臨牀、財務、行政和患者參與成果。它通過三個部門運作:軟件和分析、網絡解決方案和技術支持的服務。

Read More

閲讀更多內容

  • Get a free copy of the StockNews.com research report on Change Healthcare (CHNG)
  • Is There a Reasonable Price to Buy Stitch Fix Stock?
  • 3 Smid Caps Under $20 Set to Recover
  • Continuining to Assess Tesla's Future As The EV Market Becomes Increasingly Competitive
  • 3 Stocks to Buy Ahead of Q2 Earnings
  • Why a Recession is Good News for Ollie's Stock
  • 免費獲取StockNews.com關於Change Healthcare(CHNG)的研究報告
  • 是否有一個合理的價格購買縫紉機修理股票?
  • 3個20美元以下的SmidCaps將回升
  • 隨着電動汽車市場競爭日益激烈,繼續評估特斯拉的未來
  • 在第二季度收益之前購買3只股票
  • 為什麼經濟衰退對奧利的股票是個好消息

Want to see what other hedge funds are holding CHNG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Change Healthcare Inc. (NASDAQ:CHNG – Get Rating).

想看看其他對衝基金持有Chng的是什麼嗎?訪問HoldingsChannel.com獲取Change Healthcare Inc.(納斯達克代碼:Chng-Get Rating)的最新13F備案和內幕交易信息。

Receive News & Ratings for Change Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Change Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.

接受《改變醫療保健日報》的新聞和評級-在下面輸入您的電子郵件地址,通過MarketBeat.com的免費每日電子郵件時事通訊接收最新新聞和分析師對Change Healthcare及相關公司的評級的每日摘要。

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論